Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer
Project SOAR Awakenings: Randomized Controlled Trial for Black American Women Diagnosed With Breast Cancer
1 other identifier
interventional
90
1 country
1
Brief Summary
The goal of this clinical trial is to test an approach to promote well-being in Black American women diagnosed with breast cancer. The main questions it aims to answer are:
- Can the Project SOAR (Speaking Our African American Realities) Awakenings online intervention improve depressive symptoms in Black American women diagnosed with breast cancer?
- Can the Project SOAR (Speaking Our African American Realities) Awakenings intervention improve fatigue in Black American women diagnosed with breast cancer?
- Can the Project SOAR (Speaking Our African American Realities) Awakenings intervention improve well-being in Black American women diagnosed with breast cancer? Researchers will compare the Awakenings online intervention to a comparison condition, to see if women in the Awakenings group improve on depressive symptoms, fatigue, and well-being more than women in the comparison group. Women in the comparison condition will receive materials by mail to use on their own. Participants will:
- be randomized (selected by chance) to take part in four Project SOAR Gatherings, which are small group, 90-minute to two-hour online discussions with other Black American women diagnosed with breast cancer and are designed to promote well-being OR to a comparison group. Rev. Dr.(Hon) Tammie Denyse, a 20-year breast cancer survivor and patient advocate, will lead the Gatherings, along with other experts.
- devote about eight hours for women in the Project SOAR Gatherings discussions and two hours for women in the comparison group.
- complete online questionnaires at the beginning of the study and one month and three months later.
- receive a box of resources (e.g., book, cup, blanket, journal) designed to promote well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Jul 2025
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2025
CompletedFirst Submitted
Initial submission to the registry
September 3, 2025
CompletedFirst Posted
Study publicly available on registry
October 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
January 26, 2026
August 1, 2025
11 months
September 3, 2025
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depressive symptoms - Center for Epidemiologic Studies-Depression scale
Validated self-report measure of depressive symptoms; range = 0-60; higher scores = greater depressive symptoms
Baseline, 1 month post-baseline, 4 months post-baseline
Fatigue - PROMIS Fatigue Short Form 7a; range = 7 - 35; higher scores indicate higher fatigue
A validated self-report measure of fatigue
Baseline, 1 month post-baseline, 4 months post-baseline
Secondary Outcomes (1)
Well-being-World Health Organization-Five Well-Being Index; range = 0 - 25; high scores indicate higher well-being
Baseline, 1 month post-baseline, 4 months post-baseline
Other Outcomes (5)
Self-compassion - Neff Self-Kindness subscale; range = 5 - 25; higher scores indicate higher self-kindness
Baseline, 1 month post-baseline, 4 months post-baseline
Cancer-related coping through emotional expression - Emotional Approach Coping Emotional Expression subscale; range mean = 1 - 4; higher scores indicate higher coping with cancer through emotional expression;
Baseline, 1 month post-baseline, 4 months post-baseline
Cancer-related coping through avoidance - COPE Avoidance-oriented coping subscales; range mean = 1-4; higher scores indicate higher coping with cancer through avoidance
Baseline, 1 month post-baseline, 4 months post-baseline
- +2 more other outcomes
Study Arms (2)
Project SOAR Comparison Group
OTHERBlack American women diagnosed with breast cancer in this arm will receive a care box with resources for Black American women diagnosed with breast cancer.
Project SOAR Awakenings intervention
EXPERIMENTALFour Project SOAR Awakenings sessions will be conducted electronically (Zoom) by experts in a group format (12-18 participants/group) with Black American women diagnosed with breast cancer. The Strong Black Woman concept and other culturally curated topics will be discussed as they apply to group members' experience of breast cancer. All women in the study will receive a care box with resources for Black American women diagnosed with breast cancer.
Interventions
Four Project SOAR Awakenings sessions will be conducted electronically (Zoom) by experts in a group format (12-18 participants/group) with Black American women diagnosed with breast cancer. The Strong Black Woman concept and other culturally curated topics will be discussed as they apply to group members' experience of breast cancer. All women in the study will receive a care box with resources for Black American women diagnosed with breast cancer.
Black American women diagnosed with breast cancer in this arm will receive a care box with resources for Black American women diagnosed with breast cancer.
Eligibility Criteria
You may qualify if:
- identifying as a woman at least 18 years of age (not limited to cisgender Black American women);
- identifying as Black (African) American;
- diagnosed with breast cancer of any stage and any diagnosis duration;
- able to speak and read English;
- residing in the United States;
- access to the internet/Zoom.
You may not qualify if:
- men diagnosed with breast cancer,
- non-English speaker
- nonresident of the United States
- no internet access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA
Los Angeles, California, 90095-1563, United States
Related Publications (4)
Owoyemi P, Denyse T, Pageot YK, Martin KJ, DeLuz KD, Kim JHJ, Stanton AL. "You [God] Gotta Go Through It With Me": Black Women Navigating Spirituality During the Breast Cancer Journey. Psychooncology. 2025 Jan;34(1):e70085. doi: 10.1002/pon.70085.
PMID: 39853607BACKGROUNDDenyse T, Martin KJ, Kim JHJ, Pageot YK, Owoyemi P, DeLuz KD, Stanton AL. "No Complaining, No Crying": A Qualitative Study of the Strong Black Woman Schema in the Breast Cancer Context. Ann Behav Med. 2023 Aug 21;57(9):733-742. doi: 10.1093/abm/kaad029.
PMID: 37318273BACKGROUNDMartin KJ, Denyse T, Pageot YK, Kim JHJ, Owoyemi P, DeLuz KD, Stanton AL. "I'm Fighting for My Life": Exploring Interactions Between Black Women with Breast Cancer and Healthcare Providers. Qual Health Res. 2023 Jul;33(8-9):753-764. doi: 10.1177/10497323231168581. Epub 2023 May 22.
PMID: 37212719BACKGROUNDDenyse T, Martin KJ, Stanton AL. The Ubuntu Approach in Project SOAR (Speaking Our African American Realities): Building a robust community-academic partnership and culturally curated focus groups. Soc Sci Med. 2022 Dec;314:115452. doi: 10.1016/j.socscimed.2022.115452. Epub 2022 Oct 12.
PMID: 36274454BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annette L Stanton, PhD
University of California, Los Angeles
- PRINCIPAL INVESTIGATOR
Tammie Denyse, MDiv Dr(Hon)
Carrie's TOUCH
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor
Study Record Dates
First Submitted
September 3, 2025
First Posted
October 6, 2025
Study Start
July 25, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
January 26, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Anticipated 2026-2030.
- Access Criteria
- To be determined.
De-identified data will be shared once the trial is complete and major publications have been accepted.